ArticleSystematic reviews2013

Safety, effectiveness, and cost of long-acting versus intermediate-acting insulin for type 1 diabetes: protocol for a systematic review and network meta-analysis.

Andrea C Tricco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.